The US Food and Drug Administration has given approval to the first new gout drug to appear on the market in 40 years. Gout is an intensely painful form of arthritis. The new drug, febuxostat, will be marketed in the US under the name Uloric by Takeda Pharmaceuticals. Febuxostat lower the concentration of uric acid in the blood of people with gout. It has been shown to be effective in clinical trials and is safe for patient with kidney or liver problems.
Posts Tagged ‘Takeda’
February 16, 2009
First New Gout Drug In 40 Years »
About Daily Dose
Welcome to RightHealth Daily Dose! We feature the one health item you simply cannot afford to miss.
About Dr. Steven Chang
Dr. Steven Chang, the author of DailyDose, is a staff physician with Kosmix RightHealth. Dr. Chang practices Family Medicine at the University of California Davis Medical Center, where his medical interests include both pediatric and geriatric care, public health, gay and lesbian health, and sleep medicine. Dr. Chang trained at the Stanford University affiliated O'Connor Hospital, and was a research fellow at the National Institute of Health. He holds an M.D. from McGill University and a BA in Public Health from Johns Hopkins University.
Get your dose by email
Recent Posts
- Parkinson's Related To Chemical Exposure
- Concussions' Chronic Effects On Mental Health
- Free Text Messages Guide Mothers-To-Be Through Pregnancy
- 'Longevity Gene' Slows Decline In Brain Function
- Americans Hesitant To Seek Mental Health Care
Categories
Archives
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
Blogroll
- The Body Odd
- The Checkup
- davidrothman.net
- DiabetesMine
- Health Blog
- The Health Care Blog
- Health Check
- Junkfood Science
- KevinMD
- Mark's Daily Apple
- TeeVee
- Well